Dr. med. Marcel Vetter

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. (2025) Roth D, Düll M, Horst LJ, Lindemann A, Malzer X, Koop K, Zundler S, et al. Journal article Risk factors associated with complications of palliative drainage of ascites with tunneled peritoneal catheters (2025) Machnik D, Fischer S, Vetter M, Lamprecht-Bailer R, Rouse-Merkel R, Klett D, Neurath M, et al. Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article Determination and prospective validation of cut-off values for the diagnosis of liver cirrhosis for point shear-wave elastography/acoustic radiation force impulse imaging using the ACUSON Sequoia ultrasound system (2024) Meitner-Schellhaas B, Schüler S, Vogl T, Jesper D, Vetter M, Waldner M, Strobel D Journal article Artificial intelligence for the classification of focal liver lesions in ultrasound - a systematic review. (2023) Vetter M, Waldner M, Zundler S, Klett D, Bocklitz T, Neurath M, Adler W, Jesper D Journal article Chronic pruritus represents a major burden in non-cholestatic hepatobiliary disorders (2022) Düll M, Karlen V, Vetter M, Dietrich P, Kupfer J, Neurath M, Kremer A Conference contribution Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021) Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al. Journal article Therapy adaption by dose titration of obeticholic acid in a 57-year-old female patient with PBC and advanced liver fibrosis (2021) Vetter M, Dietrich P, Kremer A Conference contribution Severity of COVID-19 disease is related to hyperactivation and altered migratory capacity of T cells (2021) Spörl S, Kremer AL, Aigner M, Eisenhauer N, Koch P, Meretuk L, Loeffler P, et al. Conference contribution Successful treatment of COVID-19 with convalescent plasma in B-cell depleted patients may promote cellular immunity (2021) Kremer A, Kremer A, Willam C, Verhagen J, Achenbach S, Van Der Meiden E, Lang V, et al. Conference contribution